Cargando…

Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients

Sleep disorders are the common side effects of beta blockers. Beta blockers have been shown to reduce the production of melatonin via specific inhibition of adrenergic beta1-receptors. Exogenous melatonin, taken in the evening as a supplement, could reduce the central nervous system (CNS) side effec...

Descripción completa

Detalles Bibliográficos
Autor principal: Fares, Auda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications Pvt Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195193/
https://www.ncbi.nlm.nih.gov/pubmed/22022142
http://dx.doi.org/10.4103/0975-3583.85261
_version_ 1782214087806025728
author Fares, Auda
author_facet Fares, Auda
author_sort Fares, Auda
collection PubMed
description Sleep disorders are the common side effects of beta blockers. Beta blockers have been shown to reduce the production of melatonin via specific inhibition of adrenergic beta1-receptors. Exogenous melatonin, taken in the evening as a supplement, could reduce the central nervous system (CNS) side effects (sleep disorder) associated with beta-adrenergic receptor blockers as well as the potential risk associated with reduction of the melatonin synthesis.
format Online
Article
Text
id pubmed-3195193
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-31951932011-10-21 Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients Fares, Auda J Cardiovasc Dis Res Review Article Sleep disorders are the common side effects of beta blockers. Beta blockers have been shown to reduce the production of melatonin via specific inhibition of adrenergic beta1-receptors. Exogenous melatonin, taken in the evening as a supplement, could reduce the central nervous system (CNS) side effects (sleep disorder) associated with beta-adrenergic receptor blockers as well as the potential risk associated with reduction of the melatonin synthesis. Medknow Publications Pvt Ltd 2011 /pmc/articles/PMC3195193/ /pubmed/22022142 http://dx.doi.org/10.4103/0975-3583.85261 Text en Copyright: © Journal of Cardiovascular Disease Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Fares, Auda
Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients
title Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients
title_full Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients
title_fullStr Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients
title_full_unstemmed Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients
title_short Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients
title_sort night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195193/
https://www.ncbi.nlm.nih.gov/pubmed/22022142
http://dx.doi.org/10.4103/0975-3583.85261
work_keys_str_mv AT faresauda nighttimeexogenousmelatoninadministrationmaybeabeneficialtreatmentforsleepingdisordersinbetablockerpatients